Seltorexant Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since May 2026

Also known as: JNJ 42847922, JNJ-42847922

Pipeline

Phase 3: 2

Top Sponsors

Janssen Research & Development, LLC2

Indications

Depression2
Depressive Disorder, Major2

Birmingham, Alabama1 trial

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

University of Alabama at Birmingham

Phase 3

Doral, Florida1 trial

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

UHC Research

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.